<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93909">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01680055</url>
  </required_header>
  <id_info>
    <org_study_id>Aplastic Anemia 1</org_study_id>
    <nct_id>NCT01680055</nct_id>
  </id_info>
  <brief_title>Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their Receptors</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <authority>China: National Natural Science Foundation</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to collect bone marrow and/or peripheral blood cells and plasma, for
      the analysis of adhesion molecules, chemokines and their receptors from newly-diagnosed
      aplastic anemia patients, and patients treated with antithymocyte globulin plus cyclosporine
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>hematologic response</measure>
    <time_frame>6 months following antithymocyte globulin plus cyclosporine treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>hematologic response at 6 months following antithymocyte globulin plus cyclosporine treatment, defined as no longer meeting the criteria for severe aplastic anemia</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Aplastic Anemia</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>AA-ATG</arm_group_label>
    <description>Acquired Aplastic Anemia Patients Treated with Antithymocyte Globulin plus Cyclosporine</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients With Aplastic Anemia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who fulfilled entry criteria of acquired aplastic anemia age range 16-70
             years

        Exclusion Criteria:

          -  Patients complicated with diabetes, tumor, pregnancy, active infection, or connective
             tissue diseases, such as systemic lupus erythematosus.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Peng, MD</last_name>
      <phone>13553157577</phone>
      <email>junpeng88@sina.com.cn</email>
    </contact>
    <investigator>
      <last_name>Ming Hou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 3, 2012</lastchanged_date>
  <firstreceived_date>September 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Ming Hou</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Aplastic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
